BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9934852)

  • 1. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
    Rodríguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE
    Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology.
    Rodríguez-Burford C; Steele VE; Anderson AS; Stockard CR; Weiss HL; Eto I; Johanning GL; Grizzle WE; Grubbs CJ
    Nutr Cancer; 2002; 43(1):67-75. PubMed ID: 12467137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention.
    Rodríguez-Burford C; Lubet RA; Steele VE; Eto I; Bandy M; Juliana MM; Weiss HL; Grizzle WE; Kelloff GJ; Grubbs CJ
    Oncol Rep; 2001; 8(2):373-9. PubMed ID: 11182059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of delayed administration of retinyl acetate on mammary carcinogenesis.
    McCormick DL; Moon RC
    Cancer Res; 1982 Jul; 42(7):2639-43. PubMed ID: 7083156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis.
    Crist KA; Wang Y; Lubet RA; Steele VE; Kelloff GJ; You M
    J Cell Biochem Suppl; 1997; 27():92-9. PubMed ID: 9591198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
    Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
    Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
    Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
    Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
    Lubet RA; Steele VE; DeCoster R; Bowden C; You M; Juliana MM; Eto I; Kelloff GJ; Grubbs CJ
    Carcinogenesis; 1998 Aug; 19(8):1345-51. PubMed ID: 9744527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
    Green A; Shilkaitis A; Christov K
    Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between 4-HPR and diet in NMU-induced mammary tumorigenesis.
    Cohen LA; Epstein M; Saa-Pabon V; Meschter C; Zang E
    Nutr Cancer; 1994; 21(3):271-83. PubMed ID: 8072880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
    Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention.
    Cope MB; Steele VE; Lubet RA; Eto I; Juliana MM; Hill DL; Grubbs CJ
    Oncol Rep; 2004 Feb; 11(2):465-9. PubMed ID: 14719085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats.
    Lee S; Simpson M; Nimmo M; Xu Z
    Carcinogenesis; 2004 Oct; 25(10):1879-85. PubMed ID: 15205360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats.
    Lubet RA; Steele VE; Casebolt TL; Eto I; Kelloff GJ; Grubbs CJ
    Carcinogenesis; 1994 Dec; 15(12):2775-80. PubMed ID: 8001234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis.
    Schaffer EM; Liu JZ; Green J; Dangler CA; Milner JA
    Cancer Lett; 1996 Apr; 102(1-2):199-204. PubMed ID: 8603370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer.
    Shealy YF; Frye JL; Riordan JM; Hill DL; McPhillips M; Wille JJ; Sani BP; Kalin JR; Eto I; Grubbs CJ
    Anticancer Drug Des; 1997 Jan; 12(1):15-33. PubMed ID: 9051111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the duration of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat.
    Thompson HJ; Becci PJ; Brown CC; Moon RC
    Cancer Res; 1979 Oct; 39(10):3977-80. PubMed ID: 476636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
    Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
    Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary effects of conjugated docosahexaenoic acid on N-methyl-N-nitrosourea-induced mammary carcinogenesis in female Sprague-Dawley rats.
    Danbara N; Uehara N; Shikata N; Takada H; Hada T; Tsubura A
    Oncol Rep; 2004 Nov; 12(5):1079-85. PubMed ID: 15492796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
    Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ
    Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.